Simparo Surgical Funding & Investors

We have created a new standard of care in the most operated joint in hand. Our device reduces procedural time by over 65% and promotes faster patient recovery. This is the first step in expanded procedures and biologic applications to replace traditional implant arthroplasty methods.We are an orthopedic surgical device company in the extremity marketplace. We have 4 partners with nearly 90… · More years of collective experience in orthopedic device design, manufacture and commercialization. Our flagship product solves a problem that affects over 12 million Americans and is well positioned to become the new standard of care for carpometacarpal (CMC) repair. The extremity market is the fastest growing segment in orthopedics.